<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03837236</url>
  </required_header>
  <id_info>
    <org_study_id>25</org_study_id>
    <nct_id>NCT03837236</nct_id>
  </id_info>
  <brief_title>Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease</brief_title>
  <official_title>Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Behçet's Disease (BD) is a chronic, inflammatory, rheumatic disease that is characterized by&#xD;
      mucocutaneous lesions. Promoting physical activity level is one of the major goals in the&#xD;
      management of patients with rheumatic diseases, it is important to determine the factors&#xD;
      affecting physical activity level and exercise barriers. The aim of this study is to&#xD;
      investigate physical activity level and exercise barriers in patients with BD. Physical&#xD;
      activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep&#xD;
      disorders, aerobic capacity and quality of life will be assessed using International Physical&#xD;
      Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease&#xD;
      Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI),&#xD;
      McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk&#xD;
      test and Behçet's Disease Quality of Life Questionnaire, respectively.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Behçet's Disease (BD) is a chronic, inflammatory, rheumatic disease that is characterized by&#xD;
      mucocutaneous lesions and can be seen major organ involvement such as eyes, musculoskeletal&#xD;
      system, gastrointestinal system and central nervous system. Gender and clinical findings&#xD;
      effect the prognosis of the disease. Physical activity is all body movements requiring energy&#xD;
      expenditure over basal metabolism and contraction of skeletal muscle. Promoting physical&#xD;
      activity level is one of the major goals in the management of patients with rheumatic&#xD;
      diseases because of negative impact of sedentary lifestyle which depends on rheumatic&#xD;
      involvement.Impaired quality of life, aerobic capacity, respiratory function and life&#xD;
      satisfaction, sleep disorders, depression, anxiety and fatigue are seen commonly in BD&#xD;
      patients like the other rheumatic diseases. Because of these symptoms, it is possible and&#xD;
      expected that BD patients have low physical activity level. Considering that regular physical&#xD;
      activity effects survival for patients and healthy people, it is important to determine the&#xD;
      factors affecting physical activity level and exercise barriers. The aim of this study is to&#xD;
      investigate physical activity level and exercise barriers in patients with BD. Physical&#xD;
      activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep&#xD;
      disorders, aerobic capacity and quality of life will be assessed using International Physical&#xD;
      Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease&#xD;
      Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI),&#xD;
      McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk&#xD;
      test and Behçet's Disease Quality of Life Questionnaire, respectively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 8, 2019</start_date>
  <completion_date type="Anticipated">November 8, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>International Physical Activity Questionnaire (IPAQ)- Short Form</measure>
    <time_frame>1 minute</time_frame>
    <description>This questionnaire obtains information about how much time is spent while walking and in moderate and vigorous activities and sitting duration in the last 7 days. The questionnaire records the activity of four intensity levels: 1) vigorous-intensity activity, 2) moderate-intensity activity, 3) walking, and 4) sitting. Durations are multiplied by known METs per activity and the results for all items are summed for the overall physical activity score. Scores for walking and for moderate and vigorous activities are sums of corresponding item scores. A sitting question is not included in physical activity score. The questionnaire is scored as: those who score high on the IPAQ engage in vigorous intensity activity of at least 1500 MET minutes a week, those who score modarete on the IPAQ of at least 600 MET minutes a week, those who score a low level of physical activity on the IPAQ means that not meeting any of the criteria for either moderate or high levels of physical activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the Exercise Benefits/Barriers Scale</measure>
    <time_frame>2 minutes</time_frame>
    <description>It consists of 43 items including benefits of exercise (e.g. I enjoy exercise) and barriers (e.g. Exercising takes too much of my time). Benefits subscale scores range between 29 and 116 while barriers subscale scores range between 14 and 56. The higher the score on the Barriers scale, the greater the perception of barriers to exercise.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue Severity Scale</measure>
    <time_frame>2 minutes</time_frame>
    <description>This scale consists of nine questions; each question is scored from 1 to 7, in which a high FSS score indicates severe fatigue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory</measure>
    <time_frame>1 minute</time_frame>
    <description>Beck Depression Inventory consists of 21 items related to depressive symptoms such as pessimism, sense of failure, guilt, dissatisfaction, sleep, appetite and fatigue. Each item is scored between 0 and 3. Higher score means increased severity of depression. According to this scale 1-10 points are defined as normal, scores between 11-16 indicate mild mental distress, 17-20 indicate the patient is at the border points for clinical depression, 21-30 indicate moderate depression, severe depression scores are between 31-40 and 40 points above are interpreted as a very serious depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form McGill Pain Questionnaire</measure>
    <time_frame>2 minutes</time_frame>
    <description>This questionnaire consists of 11 sensory and 4 affective descriptive words. These 15 words are scored range between 0 and 4. So three type of pain scores (sensory, affective, total = sensory + affective) are obtained. In McGill Pain Questionnaire, the current level of pain is measured by Visual Analog Scale (VAS) and Likert scale consisting of 6 points (0 = no pain, 1 = mild, 2 = irritating, 3 = bothersome, 4 = terrible, 5 = unbearable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behçet's Disease Quality of Life Questionnaire</measure>
    <time_frame>5 minutes</time_frame>
    <description>It consists of 15 items about difficulties in social, psychological and daily living effects for patients with BD. All questions have the same five answers including; always (4 points), usually (3 points), sometimes (2 points), rarely (1 point), never (0 point). Total score is calculated by collecting all points, which ranges between 0 and 60 points. The higher score indicated the high quality of life level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index</measure>
    <time_frame>2 minutes</time_frame>
    <description>It is a self-assessment questionnaire which evaluates sleep quality and disturbances over a 1 month time interval. It consists of 19 self-rated items and five questions rated by the bedpartner or roommate which is not included to the total score. . These 19 items are grouped into seven component scores, each weighted equally on a 0-3 scale. The seven component scores are then summed yo yield a global Pittsburgh Sleep Quality Index score, which has a range of 0-2 and the higher score indicates worse sleep quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>6 minutes</time_frame>
    <description>6MWT is a distance required to fast-paced walk on flat floor in length 30 meters. The aim of the 6MWT is to walk as long as the patient can walk in 6 minutes. Dyspnoea and fatigue level are recorded at the end of the test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behçet Disease Current Activity Form (BDCAF)</measure>
    <time_frame>5 minutes</time_frame>
    <description>It has 12 components; headache, oral ulcer, genital ulcer, arthralgia, erythema, skin pustule, arthritis, nausea/vomiting/abdominal pain, diarrhea or frank blood per rectum, eye symptoms, nervous and vascular system symptoms. Each component is scored as absent (0 point) or present (1 point) and final BDCAF score is sum of all components with a maximum of 12.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Behçet Disease</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation parameters will be performed to the patients. Physical activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep disorders, aerobic capacity and quality of life will be assessed using International Physical Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk test and Behçet's Disease Quality of Life Questionnaire, respectively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Study group</intervention_name>
    <description>Evaluation parameters will be performed to the patients. Physical activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep disorders, aerobic capacity and quality of life will be assessed using International Physical Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk test and Behçet's Disease Quality of Life Questionnaire, respectively.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Being followed at the Gazi University Faculty of Medicine, Department of Rheumatology&#xD;
             with Behçet Disease met the diagnostic criteria proposed at the International Study&#xD;
             Group of Behçet Disease.&#xD;
&#xD;
          -  The age of 18- 65 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Illiterate,&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Diagnosed with malignancy&#xD;
&#xD;
          -  Accompaning any other rheumatic diseases except from Fibromyalgia&#xD;
&#xD;
          -  Having changes of medical treatment in the last 3 months&#xD;
&#xD;
          -  having dysfunction that limited physical activity such as severe neurological&#xD;
             impairment, immobility or cooperation deficits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deran Oskay</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University Faculty of Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Songul Baglan Yentur</last_name>
    <phone>+90 312 216 26 12</phone>
    <email>songulbaglan23@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <zip>06560</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Songul Baglan Yentur</last_name>
      <phone>+90 506 272 6511</phone>
      <email>songulbaglan23@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Devrim Can Sarac</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gizem Tore</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fulden Sari</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuh Atas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mehmet Akif Ozturk</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deran Oskay</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Moses Alder N, Fisher M, Yazici Y. Behcet's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S110-3.</citation>
    <PMID>19026127</PMID>
  </results_reference>
  <results_reference>
    <citation>Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici H. Outcome measures used in clinical trials for Behcet syndrome: a systematic review. J Rheumatol. 2014 Mar;41(3):599-612. doi: 10.3899/jrheum.131249. Epub 2014 Feb 1.</citation>
    <PMID>24488418</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 8, 2019</study_first_submitted>
  <study_first_submitted_qc>February 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>February 13, 2019</last_update_submitted>
  <last_update_submitted_qc>February 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Songul Baglan Yentur</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Behçet disease</keyword>
  <keyword>Physical activity level</keyword>
  <keyword>Exercise barriers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behcet Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03837236
org study id: 25
nct id: NCT03837236
lead sponsor: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
Behçet's Disease (BD) is a chronic, inflammatory, rheumatic disease that is characterized by
      mucocutaneous lesions. Promoting physical activity level is one of the major goals in the
      management of patients with rheumatic diseases, it is important to determine the factors
      affecting physical activity level and exercise barriers. The aim of this study is to
      investigate physical activity level and exercise barriers in patients with BD. Physical
      activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep
      disorders, aerobic capacity and quality of life will be assessed using International Physical
      Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease
      Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI),
      McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk
      test and Behçet's Disease Quality of Life Questionnaire, respectively.
Behçet's Disease (BD) is a chronic, inflammatory, rheumatic disease that is characterized by
      mucocutaneous lesions and can be seen major organ involvement such as eyes, musculoskeletal
      system, gastrointestinal system and central nervous system. Gender and clinical findings
      effect the prognosis of the disease. Physical activity is all body movements requiring energy
      expenditure over basal metabolism and contraction of skeletal muscle. Promoting physical
      activity level is one of the major goals in the management of patients with rheumatic
      diseases because of negative impact of sedentary lifestyle which depends on rheumatic
      involvement.Impaired quality of life, aerobic capacity, respiratory function and life
      satisfaction, sleep disorders, depression, anxiety and fatigue are seen commonly in BD
      patients like the other rheumatic diseases. Because of these symptoms, it is possible and
      expected that BD patients have low physical activity level. Considering that regular physical
      activity effects survival for patients and healthy people, it is important to determine the
      factors affecting physical activity level and exercise barriers. The aim of this study is to
      investigate physical activity level and exercise barriers in patients with BD. Physical
      activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep
      disorders, aerobic capacity and quality of life will be assessed using International Physical
      Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease
      Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI),
      McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk
      test and Behçet's Disease Quality of Life Questionnaire, respectively.
allocation: N/A
intervention model: Single Group Assignment
primary purpose: Basic Science
masking: None (Open Label)
measure: International Physical Activity Questionnaire (IPAQ)- Short Form
time frame: 1 minute
description: This questionnaire obtains information about how much time is spent while walking and in moderate and vigorous activities and sitting duration in the last 7 days. The questionnaire records the activity of four intensity levels: 1) vigorous-intensity activity, 2) moderate-intensity activity, 3) walking, and 4) sitting. Durations are multiplied by known METs per activity and the results for all items are summed for the overall physical activity score. Scores for walking and for moderate and vigorous activities are sums of corresponding item scores. A sitting question is not included in physical activity score. The questionnaire is scored as: those who score high on the IPAQ engage in vigorous intensity activity of at least 1500 MET minutes a week, those who score modarete on the IPAQ of at least 600 MET minutes a week, those who score a low level of physical activity on the IPAQ means that not meeting any of the criteria for either moderate or high levels of physical activity.
measure: the Exercise Benefits/Barriers Scale
time frame: 2 minutes
description: It consists of 43 items including benefits of exercise (e.g. I enjoy exercise) and barriers (e.g. Exercising takes too much of my time). Benefits subscale scores range between 29 and 116 while barriers subscale scores range between 14 and 56. The higher the score on the Barriers scale, the greater the perception of barriers to exercise.
measure: Fatigue Severity Scale
time frame: 2 minutes
description: This scale consists of nine questions; each question is scored from 1 to 7, in which a high FSS score indicates severe fatigue.
measure: Beck Depression Inventory
time frame: 1 minute
description: Beck Depression Inventory consists of 21 items related to depressive symptoms such as pessimism, sense of failure, guilt, dissatisfaction, sleep, appetite and fatigue. Each item is scored between 0 and 3. Higher score means increased severity of depression. According to this scale 1-10 points are defined as normal, scores between 11-16 indicate mild mental distress, 17-20 indicate the patient is at the border points for clinical depression, 21-30 indicate moderate depression, severe depression scores are between 31-40 and 40 points above are interpreted as a very serious depression.
measure: Short Form McGill Pain Questionnaire
time frame: 2 minutes
description: This questionnaire consists of 11 sensory and 4 affective descriptive words. These 15 words are scored range between 0 and 4. So three type of pain scores (sensory, affective, total = sensory + affective) are obtained. In McGill Pain Questionnaire, the current level of pain is measured by Visual Analog Scale (VAS) and Likert scale consisting of 6 points (0 = no pain, 1 = mild, 2 = irritating, 3 = bothersome, 4 = terrible, 5 = unbearable).
measure: Behçet's Disease Quality of Life Questionnaire
time frame: 5 minutes
description: It consists of 15 items about difficulties in social, psychological and daily living effects for patients with BD. All questions have the same five answers including; always (4 points), usually (3 points), sometimes (2 points), rarely (1 point), never (0 point). Total score is calculated by collecting all points, which ranges between 0 and 60 points. The higher score indicated the high quality of life level.
measure: Pittsburgh Sleep Quality Index
time frame: 2 minutes
description: It is a self-assessment questionnaire which evaluates sleep quality and disturbances over a 1 month time interval. It consists of 19 self-rated items and five questions rated by the bedpartner or roommate which is not included to the total score. . These 19 items are grouped into seven component scores, each weighted equally on a 0-3 scale. The seven component scores are then summed yo yield a global Pittsburgh Sleep Quality Index score, which has a range of 0-2 and the higher score indicates worse sleep quality.
measure: 6 minute walk test
time frame: 6 minutes
description: 6MWT is a distance required to fast-paced walk on flat floor in length 30 meters. The aim of the 6MWT is to walk as long as the patient can walk in 6 minutes. Dyspnoea and fatigue level are recorded at the end of the test.
measure: Behçet Disease Current Activity Form (BDCAF)
time frame: 5 minutes
description: It has 12 components; headache, oral ulcer, genital ulcer, arthralgia, erythema, skin pustule, arthritis, nausea/vomiting/abdominal pain, diarrhea or frank blood per rectum, eye symptoms, nervous and vascular system symptoms. Each component is scored as absent (0 point) or present (1 point) and final BDCAF score is sum of all components with a maximum of 12.
arm group label: Study group
arm group type: Experimental
description: Evaluation parameters will be performed to the patients. Physical activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep disorders, aerobic capacity and quality of life will be assessed using International Physical Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk test and Behçet's Disease Quality of Life Questionnaire, respectively.
intervention type: Other
intervention name: Study group
description: Evaluation parameters will be performed to the patients. Physical activity level, exercise barriers, disease activity, fatigue, depression, pain, sleep disorders, aerobic capacity and quality of life will be assessed using International Physical Activity Questionnaire-Short Form (IPAQ),Exercise Benefits/Barriers Scale, Behçet Disease Current Activity Form (BDCAF), Fatigue Severity Scale (FSS), Beck Depression Inventory (BDI), McGill Pain Questionnaire- Short Form (MPQ-SF), Pittsburgh Sleep Quality Index, 6 minute walk test and Behçet's Disease Quality of Life Questionnaire, respectively.
arm group label: Study group
criteria: 
gender: All
minimum age: 18 Years
maximum age: 65 Years
healthy volunteers: No
last name: Deran Oskay
role: Study Director
affiliation: Gazi University Faculty of Health Sciences
last name: Songul Baglan Yentur
phone: +90 312 216 26 12
email: songulbaglan23@hotmail.com
facility: 
status: Recruiting
contact: 
investigator: 
investigator: 
investigator: 
investigator: 
investigator: 
investigator: 
country: Turkey
citation: Moses Alder N, Fisher M, Yazici Y. Behcet's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S110-3.
PMID: 19026127
citation: Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici H. Outcome measures used in clinical trials for Behcet syndrome: a systematic review. J Rheumatol. 2014 Mar;41(3):599-612. doi: 10.3899/jrheum.131249. Epub 2014 Feb 1.
PMID: 24488418
responsible party type: Principal Investigator
investigator affiliation: Gazi University
investigator full name: Songul Baglan Yentur
investigator title: Research Assistant
mesh term: Behcet Syndrome
sharing ipd: No